IpiNovyx Bio
Signal active
Organization
Contact Information
Overview
IpiNovyx Bio is a biopharmaceutical company developing a platform of best-in-class immunoproteasome modulating therapeutics to transform the treatment of autoimmune and inflammatory diseases.
About
Industries
Biotechnology
Founded
2021
Employees
1-10
Headquarters locations
New York, New York, United States, North America
Social
Profile Resume
IpiNovyx Bio headquartered in New York, New York, United States, North America, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $40.0M in funding across 4 round(s). With a team of 1-10 employees, IpiNovyx Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - IpiNovyx Bio, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
8
Lead Investors
0
Total Funding Amount
$10.0M
Details
1
IpiNovyx Bio has raised a total of $10.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 10.0M |
Investors
IpiNovyx Bio is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Pathway Bioventures | - | FUNDING ROUND - Pathway Bioventures | 10.0M |
| Patrick Spaulding Ryan Ph.D | - | FUNDING ROUND - Patrick Spaulding Ryan Ph.D | 10.0M |
| IpiNovyx Bio | - | FUNDING ROUND - IpiNovyx Bio | 10.0M |
| Generation Ventures | - | FUNDING ROUND - Generation Ventures | 10.0M |